Close Menu
Home » Vanderbilt Spins Out Nashville Biosciences to Offer BioVU, PheWAS Services to Pharma

Vanderbilt Spins Out Nashville Biosciences to Offer BioVU, PheWAS Services to Pharma

Apr 04, 2018
|
Neil Versel
Premium

CHICAGO (GenomeWeb) – Vanderbilt University Medical Center in Nashville, Tennessee, is putting its genomics and bioinformatics expertise behind a newly unveiled commercial entity offering services and technology to the pharmaceutical and diagnostics industries.

Called Nashville Biosciences, the wholly owned subsidiary of Vanderbilt will lean heavily on BioVU, Vanderbilt's bank of longitudinal medical records and DNA samples that now contains more than 250,000 specimens.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

If They Don't Know...

Bloomberg Law writes that the Genetic Information Nondiscrimination Act may work better as a privacy, rather than anti-discrimination, law.

New Startup from Avey

TechCrunch reports that Linda Avey has a new personal genomics startup that's focusing on India.

No Longer 'Uncontested'

A new report finds that though the US has increased its activity in science and engineering, its global share of that activity has fallen in some areas, according to Inside Higher Ed.

Nature Papers Include Analysis of Rapeseed Genome, Target Enrichment Method for Metagenomics

In Nature this week: genomic analysis of rapeseed, universal target enrichment method for metagenomic sequencing, and more.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

What's Popular?

In Informatics

  1. Illumina Targets Single-Cell, Oncology Applications With New NextSeq Platform

    Premium

  2. Charles River Partners With Fios Genomics for Analytics Services

  3. IARPA Commits $48M to DNA Data Storage

  4. Color Partners With Sanford Health on Clinical Genomics

  5. Integrated Single-Cell RNA-Seq, Array Spatial Transcriptomics Analysis Puts Cells Into Context

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.